ITC/ATA Studies Validate Thyroid Dx Tests From Veracyte, Interpace, Rosetta | GenomeWeb

NEW YORK (GenomeWeb) —Studies presented this week at the International Thyroid Congress and Annual Meeting of the American Thyroid Association (ITC/ATA) demonstrated clinical validation or long-term utility of molecular thyroid nodule classifier tests from Veracyte, Interpace Diagnostics, and Rosetta Genomics. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.